Dilute Betadine Lavage in the Prevention of Postoperative Infection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the efficacy of a dilute betadine solution in reducing infectious complications in revision total knee arthroplasty. The investigators will enroll patients who are scheduled to undergo a revision total knee arthroplasty. Patients will be randomized into two groups. The treatment group will receive a dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000ml of sterile saline irrigation and the control group will receive the 2000ml sterile saline lavage alone.
| Condition | Intervention | Phase |
|---|---|---|
|
Prosthesis-Related Infections Arthroplasty |
Procedure: Betadine Lavage Procedure: Saline Lavage |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention |
| Official Title: | Efficacy of a Dilute Betadine Lavage in the Prevention of Postoperative Infection in Revision Total Knee Arthroplasty |
- Infection Rate [ Time Frame: 12 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 600 |
| Study Start Date: | August 2010 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Betadine Lavage
dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000ml of sterile saline irrigation
|
Procedure: Betadine Lavage
Following revision knee surgery, a dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000 ml of sterile saline irrigation
Other Names:
|
|
Placebo Comparator: Saline Lavage
2000 ml sterile saline lavage alone
|
Procedure: Saline Lavage
Following revision knee surgery, 2000ml sterile saline lavage prior to closure
Other Names:
|
Detailed Description:
Infections in total knee arthroplasty are still a major source of morbidity and mortality in Orthopaedics. They often necessitate long term antibiotics, reoperation, and can lead to further complications such as sepsis or even death. Infection prevention remains one of the primary goals of an orthopedic surgeon. While most sources report the infection rate for primary total knee arthroplasty to be less than 1%, the reported rate for infection in revision total knee arthroplasties has been reported to be as high as 5.6%. Despite steps taken towards infection prevention such as proper administration of preoperative antibiotics, strict adherence to sterile methods, and meticulous sterile preparation of the surgical site; infection remains higher in the total knee revision arthroplasty patient population when compared to primary total knee arthroplasty. A dilute betadine lavage (0.35% to 1% povidone iodine) prior to surgical closure has been shown in general surgical procedures as well as orthopaedic spine surgeries to reduce the infection rate in their patients, but this has not been examined in total joint arthroplasty.
The study will enroll patients who are scheduled to undergo a revision total knee arthroplasty. Patients will be randomized into two groups. The treatment group will receive a dilute betadine lavage prior to surgical closure for 3 minutes followed by 2000ml of sterile saline irrigation and the control group will receive the 2000ml sterile saline lavage alone. All other treatment will be standard of care.
Subjects will then be followed for one year post surgery for infection, as defined by Appendix 1, at intervals of 2 weeks, 6 weeks, 3 months, and one year from the date of surgery. During these visits patients will receive standard post operative care which includes infection screening. If an infection is clinically suspected with symptoms such as warmth and erythema over the joint, reduced mobility of the joint, and increasing pain at the joint, then infection data will be collected which will consist of a Erythrocyte Sedimentation Rate, C-Reactive Protein levels and a synovial fluid sample will be taken for white blood cell count and bacterial culture.
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Scheduled to undergo revision total knee arthroplasty
Exclusion Criteria:
- Inability to provide informed consent or to comply with study assessments (e.g. due to cognitive impairment or geographic distance).
- Age ≤ 17.
- Allergy to povidone iodine.
- Any condition requiring antibiotics 14 days prior to arriving for surgery.
- Patients with chronic immunosuppression (such as HIV/AIDS).
- Unable to adhere to follow up schedule and treatment.
- Patients scheduled to undergo revision total knee arthroplasty for infectious reasons.
Contacts and Locations| Contact: Paul H Yi, BA | 312-432-2468 | paul.yi@rushortho.com |
| Contact: Craig J Della Valle, MD | 312-432-2350 | craigdv@yahoo.com |
| United States, Illinois | |
| Rush University Medical Center | Recruiting |
| Chicago, Illinois, United States, 60612 | |
| Principal Investigator: Craig J Della Valle, MD | |
| Sub-Investigator: Nathan G Wetters, BS | |
| Central DuPage Hospital | Recruiting |
| Winfield, Illinois, United States, 60190 | |
| Principal Investigator: Scott Sporer, MD | |
| Principal Investigator: | Craig J Della Valle, MD | Rush University Medical Center |
More Information
No publications provided
| Responsible Party: | Craig J Delle Valle, MD, Rush University Medical Center |
| ClinicalTrials.gov Identifier: | NCT01175044 History of Changes |
| Other Study ID Numbers: | 10031106 |
| Study First Received: | August 2, 2010 |
| Last Updated: | August 29, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Rush University Medical Center:
|
Revision Knee Arthroplasty |
Betadine Lavage Infection |
Additional relevant MeSH terms:
|
Prosthesis-Related Infections Infection Postoperative Complications Pathologic Processes Povidone-Iodine |
Anti-Infective Agents, Local Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013